These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8970687)

  • 1. The population biology of the interaction between HIV-1 and HIV-2: coexistence or competitive exclusion?
    Anderson RM; May RM
    AIDS; 1996 Dec; 10(14):1663-73. PubMed ID: 8970687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach.
    Shirreff G; Pellis L; Laeyendecker O; Fraser C
    PLoS Comput Biol; 2011 Oct; 7(10):e1002185. PubMed ID: 22022243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic.
    De Cock KM; Adjorlolo G; Ekpini E; Sibailly T; Kouadio J; Maran M; Brattegaard K; Vetter KM; Doorly R; Gayle HD
    JAMA; 1993 Nov; 270(17):2083-6. PubMed ID: 8147962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV Interaction With Human Host: HIV-2 As a Model of a Less Virulent Infection.
    Azevedo-Pereira JM; Santos-Costa Q
    AIDS Rev; 2016; 18(1):44-53. PubMed ID: 26936760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-2 transmission: implications for spread of HIV-1.
    O'Brien TR
    JAMA; 1994 Mar 23-30; 271(12):903-4. PubMed ID: 8120954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Virulence of human immunodeficiency virus].
    Brun-Vézinet F; Descamps D; Loussert-Ajaka I; Simon F
    Rev Prat; 1995 Mar; 45(6):701-7. PubMed ID: 7754307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of contact structure on the transient evolution of HIV virulence.
    Park SW; Bolker BM
    PLoS Comput Biol; 2017 Mar; 13(3):e1005453. PubMed ID: 28362805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infections with human immunodeficiency viruses. Part I: pathogens, epidemiology, and clinical presentation].
    Stock I
    Med Monatsschr Pharm; 2011 Jun; 34(6):190-8; quiz 199-200. PubMed ID: 21812249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HIV-1 and HIV-2 infectivity from a prospective cohort study in Senegal.
    Gilbert PB; McKeague IW; Eisen G; Mullins C; Guéye-NDiaye A; Mboup S; Kanki PJ
    Stat Med; 2003 Feb; 22(4):573-93. PubMed ID: 12590415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proportion of HIV infections attributable to other sexually transmitted diseases in a rural Ugandan population: simulation model estimates.
    Robinson NJ; Mulder DW; Auvert B; Hayes RJ
    Int J Epidemiol; 1997 Feb; 26(1):180-9. PubMed ID: 9126519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gulliver's travels in HIVland.
    Weiss RA
    Nature; 2001 Apr; 410(6831):963-7. PubMed ID: 11309625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of HIV-1 within-host evolution on transmission dynamics.
    Theys K; Libin P; Pineda-Peña AC; Nowé A; Vandamme AM; Abecasis AB
    Curr Opin Virol; 2018 Feb; 28():92-101. PubMed ID: 29275182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease progression in HIV-1 or HIV-2-infected individuals of West African origin resident in the West.
    Jaffar S; Hall AJ
    AIDS; 1997 Sep; 11(11):1398-9. PubMed ID: 9302453
    [No Abstract]   [Full Text] [Related]  

  • 14. [Origin and evolution of human immunodeficiency viruses].
    Marian CV
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(4):167-76. PubMed ID: 20923120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences of HIV envelope protein between HIV-1 and HIV-2: possible relation to the lower virulence of HIV-2.
    Sekigawa I; Kaneko H; Neoh LP; Takeda-Hirokawa N; Akimoto H; Hishikawa T; Hashimoto H; Hirose S; Yamamoto N; Kaneko Y
    Viral Immunol; 1998; 11(1):1-8. PubMed ID: 9586692
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pathogenicity of the human immunodeficiency virus HIV-2 as seen by epidemiologists].
    Soro BN; Gershy-Damet GM; Rey JL
    Med Trop (Mars); 1993; 53(1):45-53. PubMed ID: 8505887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural protection against HIV-1 infection provided by HIV-2.
    Travers K; Mboup S; Marlink R; Guèye-Nidaye A; Siby T; Thior I; Traore I; Dieng-Sarr A; Sankalé JL; Mullins C
    Science; 1995 Jun; 268(5217):1612-5. PubMed ID: 7539936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of female-to-male transmission of HIV-1 in Thailand.
    Mastro TD; Satten GA; Nopkesorn T; Sangkharomya S; Longini IM
    Lancet; 1994 Jan; 343(8891):204-7. PubMed ID: 7904668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of HIV in Africa.
    Ewald PW
    Science; 1992 Jul; 257(5066):10. PubMed ID: 1352412
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1.
    Gottlieb GS
    AIDS; 2013 Jan; 27(1):135-7. PubMed ID: 23221427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.